The long-term effect of verapamil on plasma digoxin concentration and renal digoxin clearance in healthy subjects
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 22 (2) , 123-127
- https://doi.org/10.1007/bf00542456
Abstract
Single-dose investigations in healthy subjects have demonstrated substantial impairment of renal and extrarenal clearance of digoxin during coadministration of verapamil. A longitudinal study has been performed to assess the changes in digoxin disposition during long-term verapamil therapy. After one week of verapamil 240 mg/d mean plasma digoxin had risen from 0.21±0.01 ng/ml (SE) to 0.34±0.01 ng/ml (ppp<0.001) after six weeks of verapamil co-administration, and this elevation persisted throughout the study. The verapamil-induced suppression of renal digoxin elimination disappears over a few weeks of drug exposure, whereas the inhibition of the extrarenal clearance of digoxin seems to persist.Keywords
This publication has 8 references indexed in Scilit:
- Digoxin-verapamil interactionClinical Pharmacology & Therapeutics, 1981
- DIGOXIN PLASMA CONCENTRATIONS AND NIFEDIPINEThe Lancet, 1981
- Verapamil-Digoxin InteractionNew England Journal of Medicine, 1980
- The Effect of Quinidine on Digoxin Kinetics in Cardiac PatientsActa Medica Scandinavica, 1980
- The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therPublished by Wiley ,1979
- Digoxin-Quinidine InteractionNew England Journal of Medicine, 1979
- Spironolactone‐induced changes in digoxin kineticsClinical Pharmacology & Therapeutics, 1978
- INCREASED CLEARANCE OF DIGOXIN IN RABBITS DURING REPEATED ADMINISTRATION1978